Post-PCI Clinical Outcomes of Reduced Dose Prasugrel in Comparison to Clopidogrel
. Maryam, Mohammadi Fizza Khan, Farheen Sultana, Ofia Mushtaq, Marwah Sultana, Gurrala Rajashekhar Reddy, Abhishek Golla & Kazi Jawwad · Asian Journal of Cardiology Research · 2022
Introduction: Patients with ACS undergoing PCI with drug-eluting stent (DES), a one-year regimen with Dual Antiplatelet therapy (DAPT) is recommended to avoid thrombotic events in which any of the two-combination therapy comprising of a P2Y12 inhibitor (Clopidogrel or Prasugrel)...
Open access
Research Article